Metraipolis › archive › dc_5d86f0c154be

6-Methyltryptamine — Wikipedia (en)

Source
Wikipedia (en)
Original
https://en.wikipedia.org/wiki/6-Methyltryptamine
License (as archived)
CC-BY-SA-4.0
Archived
2026-11-06T18:53:52.500Z
SHA-256 of the archived text
1beb2f460df0ada614fabab15275d7a227efbb18be4ac2a2eb44cdf4cf2b3e30
Stable URL of this page
https://metraipolis.com/documento/dc_5d86f0c154be

How to cite

6-Methyltryptamine — Wikipedia (en) — Wikipedia (en), https://en.wikipedia.org/wiki/6-Methyltryptamine (CC-BY-SA-4.0); archived copy: https://metraipolis.com/documento/dc_5d86f0c154be (Metraipolis archive dc_5d86f0c154be, sha256 1beb2f460df0ada614fabab15275d7a227efbb18be4ac2a2eb44cdf4cf2b3e30)
BibTeX
@misc{dc5d86f0c154be,
  title = {6-Methyltryptamine — Wikipedia (en)},
  howpublished = {Wikipedia (en)},
  url = {https://en.wikipedia.org/wiki/6-Methyltryptamine},
  note = {License CC-BY-SA-4.0; archived copy https://metraipolis.com/documento/dc_5d86f0c154be; sha256 1beb2f460df0ada614fabab15275d7a227efbb18be4ac2a2eb44cdf4cf2b3e30},
  year = {2026}
}

Archived text

Reproduced under CC-BY-SA-4.0. Attribution: Wikipedia (en), https://en.wikipedia.org/wiki/6-Methyltryptamine. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

6-Methyltryptamine (6-Me-T or 6-methyl-T; developmental code name PAL-522) is a serotonin receptor modulator and monoamine releasing agent of the tryptamine family. It is the 6-methyl derivative of tryptamine. The drug acts as a potent full agonist of the serotonin 5-HT2A receptor, with an EC50Tooltip half-maximal effective concentration of 75.3 nM and an EmaxTooltip maximal efficacy of 110%. It is about 10-fold less potent as a serotonin 5-HT2A receptor agonist than tryptamine itself. In addition to its serotonin 5-HT2A receptor agonism, 6-methyltryptamine is a serotonin–dopamine releasing agent (SDRA), with EC50 values for induction of monoamine release of 51.6 nM for serotonin, 353 nM for dopamine, and >10,000 nM for norepinephrine in rat brain synaptosomes. It shows extremely weak affinity for the dizocilpine (MK-801) site of the NMDA receptor (IC50Tooltip half-maximal inhibitory concentration = 175,000–260,000 nM). Tryptamines without substitutions at the amine or alpha carbon, such as tryptamine, serotonin (5-hydroxytryptamine; 5-HT), and 5-methoxytryptamine (5-MeO-T), are known to be very rapidly metabolized and thereby inactivated by monoamine oxidase A (MAO-A) in vivo and to have very short elimination half-lives. However, given intravenously at sufficiently high doses, tryptamine is still known to be able to produce weak and short-lived psychoactive effects in humans. The chemical synthesis of 6-methyltryptamine has been described. 6-Methyltryptamine was first described in the scientific literature by 1965. Its pharmacology was subsequently assessed in greater detail in 2014.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (deposito sistematico; retro-catalogo: tutte le voci di Wikipedia in inglese, in ordine alfabetico).
Fonte: Wikipedia in inglese, voce «6-Methyltryptamine» — https://en.wikipedia.org/wiki/6-Methyltryptamine
Wikidata Q27216235: «composto chimico» (dati Wikidata in CC0 1.0) — https://www.wikidata.org/wiki/Q27216235
Autori: i contributori di Wikipedia (cronologia: https://en.wikipedia.org/wiki/6-Methyltryptamine?action=history).
Licenza: Creative Commons Attribuzione-Condividi allo stesso modo 4.0 (CC BY-SA 4.0) — https://creativecommons.org/licenses/by-sa/4.0/. Il riuso richiede attribuzione e stessa licenza.
Estratto dell'introduzione non modificato nel contenuto; revisione 1381572412, consultata il 2026-11-06T18:50:16.150Z tramite l'API ufficiale di Wikipedia. Impronta SHA-256 dell'estratto: f3da49a44d61fe771974aeda0eb89996dab36eab278d3f61897a8d4046803a82